Entrada Therapeutics, Inc. (TRDA)
6.56
-0.55
(-7.74%)
USD |
NASDAQ |
Sep 10, 12:27
Entrada Therapeutics Price : 6.56 for Sept. 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 09, 2026 | 7.47 | 7.55 | 7.02 | 7.11 | 382044.0 |
| Sep 08, 2026 | 7.02 | 7.70 | 6.945 | 7.52 | 514214.0 |
| Sep 04, 2026 | 7.11 | 7.17 | 7.00 | 7.13 | 341729.0 |
| Sep 03, 2026 | 7.31 | 7.423 | 7.04 | 7.17 | 395559.0 |
| Sep 02, 2026 | 7.07 | 7.34 | 6.96 | 7.30 | 306543.0 |
| Sep 01, 2026 | 6.95 | 7.178 | 6.80 | 7.07 | 205484.0 |
| Aug 31, 2026 | 6.84 | 7.17 | 6.76 | 7.05 | 450412.0 |
| Aug 28, 2026 | 7.18 | 7.24 | 6.935 | 7.00 | 111601.0 |
| Aug 27, 2026 | 7.02 | 7.37 | 6.80 | 7.27 | 248603.0 |
| Aug 26, 2026 | 7.55 | 7.64 | 6.954 | 7.00 | 229320.0 |
| Aug 25, 2026 | 7.39 | 7.67 | 7.39 | 7.62 | 269980.0 |
| Aug 24, 2026 | 7.58 | 7.58 | 7.12 | 7.33 | 184249.0 |
| Aug 21, 2026 | 7.64 | 7.735 | 7.44 | 7.57 | 141017.0 |
| Aug 20, 2026 | 7.76 | 7.765 | 7.30 | 7.60 | 250039.0 |
| Aug 19, 2026 | 7.49 | 7.79 | 7.395 | 7.78 | 241839.0 |
| Aug 18, 2026 | 7.21 | 7.43 | 7.16 | 7.27 | 129755.0 |
| Aug 17, 2026 | 7.33 | 7.56 | 7.25 | 7.32 | 193113.0 |
| Aug 14, 2026 | 7.45 | 7.53 | 7.21 | 7.46 | 237986.0 |
| Aug 13, 2026 | 7.74 | 7.765 | 7.369 | 7.45 | 236442.0 |
| Aug 12, 2026 | 7.03 | 7.68 | 6.93 | 7.67 | 263660.0 |
| Aug 11, 2026 | 7.00 | 7.27 | 6.93 | 7.04 | 264102.0 |
| Aug 10, 2026 | 6.87 | 7.26 | 6.83 | 6.95 | 411842.0 |
| Aug 07, 2026 | 6.94 | 7.085 | 6.75 | 6.87 | 458070.0 |
| Aug 06, 2026 | 7.05 | 7.11 | 6.74 | 6.87 | 269972.0 |
| Aug 05, 2026 | 7.47 | 7.47 | 6.85 | 7.06 | 591550.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.62 |
| Oncolytics Biotech, Inc. | 0.7896 |
| Sangamo Therapeutics, Inc. | 0.155 |
| Sarepta Therapeutics, Inc. | 20.47 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| PS Ratio | 58.49 |
| PEG Ratio | -0.0135 |
| Price to Book Value | 1.094 |
| Earnings Yield | -60.49% |
| Market Cap | 255.42M |
| PEGY Ratio | -0.0135 |